91. Kongreß pp 181-233 | Cite as

Intensivmedizinische Behandlung des akuten Herzinfarktes in den ersten Tagen

  • K.-D. Grosser
  • H. Hochrein
  • H. G. Lasch
  • A. Sturm
  • H. W. Wiechmann
  • M. Bitter
  • W. Klein
  • E. Maurer
  • K. Vrécko
  • H.-P. Schuster
  • H. B. Stähelin
  • M. Bergener
  • G. Brüschke
  • H. J. Fahrländer
  • R. Lüthy
  • H. Mehnert
  • H. H. Raspe
  • K. P. Schüren
  • H. Losse
  • K. Kochsiek
Conference paper
Part of the Verhandlungen der Deutschen Gesellschaft für innere Medizin book series (VDGINNERE, volume 91)

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    A Multicentre International Study: Improvement in prognosis of myocardial infarction by long-term beta-adrenoreceptor blockade using practolol (1975) Br Med J 1:735–740 —Google Scholar
  2. 2.
    A Multi-centre International Study: supplementary report. Reduction in mortality after myocardial infarction with long-term beta-adrenoreceptor blockade (1977) Br Med J 2:419–421 —Google Scholar
  3. 3.
    Andersen MP, Bechsgaard P, Frederiksen Jet al. (1979) Effect of alprenolol on mortality among patients with definite or suspected acute myocardial infarction. Preliminary results. Lancet 2:865–869 —Google Scholar
  4. 4.
    Behn P, Horn I (1972) Der Einfluß einer Hypertonie auf die Prognose beim akuten Myokardinfarkt. Ber Ges In Med 8:232 —Google Scholar
  5. 5.
    Beta-Blocker Heart Attack Trial Research Group (1982) A randomized trial of propanolol in patients with acute myocardial infarction. I. Mortality results. JAMA 247:1707–1714 —Google Scholar
  6. 6.
    Bleifeld W (1977) Der Herzinfarkt. Unsere heutigen Kenntnisse und zukünftigen Aussichten. Triangel 16:69 —Google Scholar
  7. 7.
    Bodenheimer MM, Ramanathan K, Banka VS, Helfant RH (1981) Effect of progressive pressure reduction with Nitroprusside on acute myocardial infarction in humans. Ann of Intern Medic 94:435 —Google Scholar
  8. 8.
    Büyüköztürk K, Gültekin N, Deligönül U, Özkan E, Korkut F, Meric M, Erzengin F, Özcan R (1980) Acute systolic hypertension after acute myocardial infarction. Acta Cardiologica 5:341 —Google Scholar
  9. 9.
    Christensen DI, Ford M, Reading J. Castle CH (1977) Effect of hypertension on myocardial rupture after acute myocardial infarction. Chest 72:618–622 —Google Scholar
  10. 10.
    Dunn FG (1983) Hypertension and myocardial infarction. J Am Coll Cardiol 1 (2):528 —Google Scholar
  11. 11.
    Dye LE, Urthaler F, MacLean WAH, Russel RO, Rackley CE, James TN (1978) New arterial hypertension during myocardial infarction. South Med J 71:289 —Google Scholar
  12. 12.
    Forrester JS, Diamond GA, Swan HJC (1977) Correlative classification of clinical and hemodynamic function after acute myocardial infarction. Amer J Cardiol 39:137 —Google Scholar
  13. 13.
    Fox KM, Tomlinson IW, Portal RW, Aber CP (1975) Prognostic significance of acute systolic hypertension after myocardial infarction. Brit Med J 3:128 —Google Scholar
  14. 14.
    Gibson TC (1978) Blood pressure levels in acute myocardial infarction. Amer Heart J 96:475 —Google Scholar
  15. 15.
    Golikov AP, Ileva VI, Malaev G (1982) Humoral mechanism of arterial hypertension in patients in the acute phase of myocardial infarction. Cor Vasa 24:329 —Google Scholar
  16. 16.
    Gordon GD, Mabin TA, Isaacs S, Lloyd EA, Eichler HG, Opie LH (1984) Hemodynamic effects of sublinguale Nifedipine in acute cardial infarction. Am J Cardiol 53:1228 —Google Scholar
  17. 17.
    Gunnar RM, Loeb HS, Scanlon PJ, Moran JF, Johnson SA, Pifarre R (1979) Management of acute myocardial infarction and accelerating angina. Progr Cardiovasc Dis 22:1 —Google Scholar
  18. 18.
    Hjalmarson A, Elmfeldt D, Herlitz J et al. (1981) Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomized trial. Lancet 2:823–827 —Google Scholar
  19. 19.
    James TN, Isobe JH, Urthaler F (1975) Analysis of components in a cardiogenic hypertensive chemoreflex. Circulation 52:179–192 —Google Scholar
  20. 20.
    Julian DG, Jackson FS, Prescott RJ, Szekely P (1982) Controlled trial of sotalol for one year after myocardial infarction. Lancet 1:1142–1147 —Google Scholar
  21. 21.
    Lohmann FW, Dissmann T, Horn J (1973) Hypertonie und Myokardinfarkt unter besonderer Berücksichtigung des Blutdruckverhaltens nach dem Infarkt. Z F Kardiol 63:252 —Google Scholar
  22. 22.
    Mäurer W, Mehmel HC, Kübler W (1983) Die Therapie des akuten Myokardinfarktes. Internist 23:283 —Google Scholar
  23. 23.
    Melandri G, Bassein L, Petronelli FP, Tartagni F, Maresta A, Magnani B (1983) Intrahospital prognosis of acute myocardial infarction by means of discriminant analysis. G Ital Cardio 13:1 —Google Scholar
  24. 24.
    Norwegian Multicenter Study Group (1981) Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 304:801–807 —Google Scholar
  25. 25.
    Oliver MF (1975) Acute systolic hypertension during myocardial infarction. Brit Med J 3:432 —Google Scholar
  26. 26.
    Pantridge JF, Webb SW, Adgey AAJ, Geddes JS (1974) The first hour after the onset of acute myocardial infarction. In: Yu PN, Goodwin JF (eds) Progress in Cardiol. Lea and Febiger, Philadelphia, pp 65–198 —Google Scholar
  27. 27.
    Renard M, Reviere P, Jacobs R, Bernard (1938) Treatment of Hypertension in acute stage of myocardial infarction. Br Heart J 49:522 —Google Scholar
  28. 28.
    Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature. Nomenclature and criteria for diagosis heart disease. (1979) Circulation 59:607 —Google Scholar
  29. 29.
    Rudolph W, Dirschinger J (1981) Standardtherapie des akuten Herzinfarktes. Herz 6:25 —Google Scholar
  30. 30.
    Schuster P (1983) Isosorbiddinitrat oral bei akutem Myokardinfarkt. Habilitationsschrift Ruhr-Universität Bochum —Google Scholar
  31. 31.
    Spang K (1962) Kardiale Komplikationen der essentiellen Hypertonie. Verh Ges Kreislaufforschung 28:127–137 —Google Scholar
  32. 32.
    Vedin A, Hjalmarson A, Wilhelmsson C (1984) Auswirkungen auf die Letalität und Messungen der Infarktgröße nach Behandlung mit Beta-1-Selektiven und nicht selektiven Betablockern. In: Lohmann FW (ed) Die klinische Bedeutung der Beta-1-Selektivität. Verlag für angewandte Wissenschaften, München, S 113–133 —Google Scholar
  33. 33.
    Vetter NJ, Strange RC, Adams N, Oliver MF (1974) Initial metabolic and hormonal response to acute myocardial infarction. Lancet 1:284–288 —Google Scholar
  34. 34.
    Wiechmann HW, Sturm A (1983) Interaktionen und Inkompatibilitäten bei Anwendung von Antihypertensiva. Intensivmedizin 20:56 —Google Scholar
  35. 35.
    Wirtzfeld A, Klein G, Delius W, Sack D (1978) Behandlung des akuten Myokardinfarktes mit Metoprolol. Dtsch med Wochenschr 103:566 —Google Scholar
  36. 36.
    Yusuf S, Ramsdale D, Peto R, Furse L, Bennett D, Bray C, Sleight P (1980) Early intravenous atenolol treatment in suspected acute myocardial infarction. Lancet 1: 273Google Scholar
  37. 1.
    Achuff SC, Campbell RWF, Pottage A, Murray A, Prescott L, Julian DG (1975) Mexiletin zur Prävention ventrikulärer Arrhythmien bei akutem Herzinfarkt. Circ 147: 51–52 —Google Scholar
  38. 2.
    Achuff SC, Campbell RWF, Pottage A, Murray A, Prescott L, Julian DG (1977) Mexiletine in the prevention of ventricular arrhythmias in acute myocardial infarction. Postgrad med J 53:163–164 —Google Scholar
  39. 3.
    Ahnve S, Helmers C, Lundman T, Rehnqvist N, Sjögren A (1980) QTC Intervals in acute Myocardial Infarction: First-Year Prognostic Implications. Clin Cardiol 3:303–308 —Google Scholar
  40. 4.
    Balcon R, Jewitt DE, Davies JPH, Oram S (1966) A Controlled Trial of Propranolol in acute Myocardial Infarction. Lancet:918–924 —Google Scholar
  41. 5.
    Bennett MA, Wilner JM, Pentecost BL (1970) Controlled Trial of Lignocaine in Prophylaxis of ventricular Arrhythmias Complicating Myocardial Infarction. Lancet:909–911 —Google Scholar
  42. 6.
    Bloomfield SS, Romhilt DW, Te-Chuan Chou, Fowler NO (1971) Quinidine for Prophylaxis of Arrhythmias in acute Myocardial Infarction. N Engl J Med 285:980–986 —Google Scholar
  43. 7.
    Bussmann WD, Neumann K, Kaltenbach M (1984) Effects of intravenous nitroglycerin on ventricular ectopic beats in acute Myocardial Infarction. Am Heart J 107:940–944 —Google Scholar
  44. 8.
    Campbell RWF, Dolder MA, Prescott LF, Talbot RG, Murray A, Julian DG (1977) Ventricular arrhythmias after acute Myocardial Infarction treated with procainamide or mexiletine. Postgrad Med J 53:150–153 —Google Scholar
  45. 9.
    Campbell RWF, Bryson LG, Bailey BJ, Murray A, Julian DG (1979) Oral Tocainide in Suspected Acute Myocardial Infarction. Abstr Circ 59 and 60 (Supp II):70 —Google Scholar
  46. 10.
    Cohen LS, Conde CA (1978) Ventricular Dysrhythmias during the Hyperacute, Acute and Convalescent Phases of Myocardial Infarction. In: Donoso E, Lipski J (eds) Acute Myocardial Infarction. Stratton Intercontinental Medical Book Corporation, New York, p 112 —Google Scholar
  47. 11.
    Coker SJ, Parrat JR (1983) Thromboxane and Prostacyclin in the Genesis of Reperfusion Arrhythmias. Euro H J 4, Supp 3:55 —Google Scholar
  48. 12.
    Cooper WD, Kuan P, Reuben SR, Vendenburg J (1984) Cardiac arrhythmias following acute myocardial infarction: Associations with the serum potassium level and prior diuretic therapy. Euro H J 5:464–469 —Google Scholar
  49. 13.
    Donoso E, Lipski J (1978) Bradyarrhythmias and Ventricular Conduction Blocks Complicating Acute Myocardial Infarction. Role of Pacemakers. In: Donoso E, Lipski J (eds) Acute Myocardial Infarction. Stratton Intercontinental Medical Book Corporation, New York, p 169 —Google Scholar
  50. 14.
    Dubner S, Gimeno G, Elencwajg B, Quinteiro R, Tronge J, Bertolasi C (1982) Antiarrhythmic Effect of Tiapamil in Patients with Acute Myocardial Infarction. Card 69:172–180 —Google Scholar
  51. 15.
    Erhl G, Kloner RA, Alexander RW, Braunwald E (1982) Limitation of experimental infarct size by an angiotensin converting enzyme inhibitor. Circ 65:40–48 —Google Scholar
  52. 16.
    Follath F, Ritz R, Vozeh S, Wenk M (1982) Verlangsamte Lidocain-Elimination and Dosisanpassung bei Patienten mit Herzinsuffizienz. Schweiz med Wochenschr 112:789–792 —Google Scholar
  53. 17.
    Grande P, Pedersen A (1984) Myocardial infarct size: correlation with cardiac arrhythmias and sudden death. Eur H J 5:622–627 —Google Scholar
  54. 18.
    Gülker H, Thale J, Heuer H, Rose D, Bender F (1984) Comparative Antiarrhythmic action of Diltiazem during earl and late phase ventricular arrhythmias. Eur Heart J 4 (Supp E):56 —Google Scholar
  55. 19.
    Haerten K, Schepers J, Borggrefe M, Abendroth RR, Seipel L, Breithardt G (1984) Häufigkeit and prognostische Bedeutung auslösbarer ventrikulärer Arrhythmien im frühen Postinfarktstadium. Z Kardiol 73:199–205 —Google Scholar
  56. 20.
    Herlitz J, Edvardsson N, Holmberg S, Rydén L, Waagstein F, Waldenström A, Swedberg K, Hjalmarson A (1984) Göteborg Metoprolol Trial: Effects on Ar-Google Scholar
  57. rhythmias. Am J Cardiol 53:27–31 —Google Scholar
  58. 21.
    Hust MH, Nitsche K, Löllgen H (1982) QT-Verlängerung im Oberflächen-EKG — was steckt dahinter? Herz + Gefäße 2:244–246 —Google Scholar
  59. 22.
    Hust MH, Löllgen H, Just H (1983) QT-Anomalien und Arrhythmien durch Antiarrhythmika. Med Klin 78:728–731 —Google Scholar
  60. 23.
    Hust MH, Heilmann S, Bonzel T, Hohnloser S, Zeiher A, Berchtold-Kanz E, Wollschläger H, Just H (1984) Prognostische Bedeutung des QT-Intervalls nach Herzinfarkt. Schweiz med Wochenschr 114:56–58 —Google Scholar
  61. 24.
    Jennings G, Jones MBS, Bestermann EMM, Model DG, Turner PP, Kidner PH (1976) Oral Disopyramide in Prophylaxis of Arrhythmias following Myocardial Infarction. Lancet:51–54 —Google Scholar
  62. 24a.
    Kertes M, Glabus A, Murray A, Julian DG, Campbell RWF (1984) Delayed ventricular depolarization-correlation with ventricular activation and relevance to ventricular fibrillation in acute myocardial infarction. Eur Heart J 5:974–983 —Google Scholar
  63. 25.
    Klein MD, Levine PA, Ryan TJ (1980) Antiarrhythmic Efficacy, Pharmacokinetics and Clinical Safety of Tocainide in Convalescent Myocardial Infarction Patients. Chest 77:726–730 —Google Scholar
  64. 26.
    Koch-Weser J, Klein SW, Foo-Canto LL, Kastor JA, DeSanctis RW (1969) Antiarrhythmic Prophylaxis with Procainamide in acute Myocardial Infarction. N Engl J Med 281:1253–1260 —Google Scholar
  65. 27.
    Kramer JB, Corr PB (1984) Mechanisms contributing to arrhythmias during ischaemia and infarction. Eur Heart J 5:11–18 —Google Scholar
  66. 28.
    Lie KI, Wellens HJ, Van Capelle FJ, Durrer D (1974) Lidocaine in the Prevention of Primary ventricular Fibrillation. N Engl J Med 1324–1326 —Google Scholar
  67. 29.
    Lucchesi BR (1984) Rationale of Therapy in the Patient with Acute Myocardial Infarction and Life-Threatening Arrhythmias: A Focus on Bretylium. Am J Cardiol 54:14–19 —Google Scholar
  68. 30.
    Luderitz B, Naumann D’Alnoncourt C (1983) Antiarrhythmische Therapie bei Herzinfarkt. In: Herzrhythmusstörungen B. Luderitz Handbuch der Inneren Medizin. Springer, Berlin Heidelberg New York, p 897 —Google Scholar
  69. 31.
    Michorowski B, Ceremuzynski L (1983) The renin-angiotensin-aldosterone system and the clinical course of acute myocardial infarction. Eur Heart J 4:259–264 —Google Scholar
  70. 32.
    Norris RM et al. (1984) Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol. Lancet:883–886 —Google Scholar
  71. 33.
    Pitt A, Lipp H, Anderson ST (1971) Lignocaine given prophylactically to patients with acute myocardial infarction. Lancet:612–616 —Google Scholar
  72. 34.
    Potratz J, Djonlagie H, Mentzel H, 011mann D, Hackenjos B, Diederich KW (1984) Registrierung von Spätpotentialen bei akuten Infarktpatienten und ihre Beziehung vom Infarktalter, zum Auftreten von Herzrhythmusstörungen und zum plötzlichen Herztod. Intensivmed 21:211–212 —Google Scholar
  73. 34a.
    Puddu PE, Jouve R, Torresani J, Jouve A (1979) Electrocardiographic antecedents of primary ventricular fibrillation: value of QT interval prolongation in acute myocardial infarction. In: Florence international meeting on myocardial infarction. Exerpta medica, Amsterdam 1979 —Google Scholar
  74. 35.
    Rochette L, Didier JP, Moreau D, Bralat J, Opie LH (1984) Role of beta-adrenoreceptor antagonism in the prevention of reperfusion ventricular arrhythmias: effects of acebutolol, atenolol, and d-propranolol on isolated working rat hearts subject to myocardial ischemia and reperfusion. Am Heart J 107:1132–1141 —Google Scholar
  75. 36.
    Rehnqvist N (1983) Vergleich der Wirksamkeit von Rytmonorma und Lidocain bei Patienten mit akutem Myokardinfarkt und ventrikulären Extrasystolen — Ergebnis eines 24stündigen Holter-monitorings. In: Schlepper und Olsson Kardiale Rhythmusstörungen. Springer, Berlin Heidelberg New York, p 45 —Google Scholar
  76. 37.
    Schwartz PJ, Wolf S (1978) QT Intervall Prolongation as Predictor of Sudden Death in Patients with Myocardial Infarction. Circ 57:1074–1077 —Google Scholar
  77. 38.
    Tamari I, Rabinowitz B, Neufeld HN (1982) Torsade de pointes due to prenylamine controlled by lignocaine. Eur Heart J 3:309–392 —Google Scholar
  78. 39.
    Torresani J (1984) Bretylium Tosylate in Patients with Acute Myocardial Infarction. Am J Cardiol 54:21–25 —Google Scholar
  79. 40.
    Zainal N, Griffiths JW, Carmichael DJS, Bestermann EMM (1977) Oral Disopyramide for the Prevention of Arrhythmias in Patients with Acute Myocardial Infarction admitted to open wards. Lancet: 887–889Google Scholar
  80. 1.
    I. Akhtar N, Mikulic E, Cohn JN, Chaudhry MH (1975) Hemodynamic effect of Dobutamine in patients with severe heart failure. Am J Cardiol 36:202–205 —Google Scholar
  81. 2.
    Alcan KE, Stertzer SH, Wallsh E, Bruno MS, PePasquale NP (1984) Current status of intra-aortic balloon counterpulsation in critical care cardiology. Crit Care Med 12:489–495 —Google Scholar
  82. 3.
    Bassenge E (1982) Pharmakologische Basis der Therapie mit Molsidomin. Herz 7:296–306 —Google Scholar
  83. 4.
    Baumstark A, Swensson RG, Hessel SJ, Levin DC, Grossmann W, Mann JT, Abrams HL (1984) Evaluating the radiographic assessment of pulmonary venous hypertension in chronic heart disease. AJR 141: 877–884 —Google Scholar
  84. 5.
    Bayley S, Valentine H, Bennett ED (1984) The haemodynamic responses to incremental doses of intravenous nitroglycerin in left ventricular failure. Intensive Care Med 10:139–145 —Google Scholar
  85. 6.
    Benotti JR, Grossmann W, Braunwald E, Carabello BA (1980) Effects of Amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease. Circulation 62:28–34 —Google Scholar
  86. 7.
    Benotti JR, McCue J, Love D, Alpert JS (1983) Comparative inotropic therapy in heart failure patients. Circulation 68 (Suppl. 3): III-128 —Google Scholar
  87. 8.
    Bleifeld W, Hanrath P (1975) Die hämodynamische Basis der Therapie des akuten Myokardinfarktes. Deutsch Med Wochenschr 100:1345 —1350 —Google Scholar
  88. 9.
    Braunwald E, Ross J (1963) The rentricular end-diastolic pressure: an appraisal of its value in the recognition of ventricular failure in man. Am J Med 34:147–150 —Google Scholar
  89. 10.
    Brodie BR, Grossmann W, Mann T, McLaurin LP (1977) Effects of sodium nitraprusside on left ventricular diastolic pressure volume relations. J Clin Invest 59:59–68 —Google Scholar
  90. 11.
    Buschmann HJ, Dissmann W, Siemon G, Sonderkamp H, Schröder R (1967) Die arterielle Hypoxämie bei akutem Myokardinfarkt. Klin Wochenschr 45:113–121 —Google Scholar
  91. 12.
    Bussmann WD, Wehrheim HG (1983) Therapie des kardiogenen Schocks mit Dobutamin und Nitroglycerin. Deutsch Med Wochenschr 108:1273–1280 —Google Scholar
  92. 13.
    Cantelli I, Lolli C, Brunetti A, Bracchetti D (1985) Hemodynamic effects of molsidomine in patients with heart failure following acute myocardial infarction. Am Heart J 109:716–719 —Google Scholar
  93. 14.
    Carlet J, Francoual M, Lhoste F, Regnier B, Lemaire F (1980) Pharmacological treatment of pulmonary oedema. Intensive Care Med 6:113–122 —Google Scholar
  94. 15.
    Crexells C, Chatterjee K, Forrester JS, Dikshit K, Swan HJC (1973) Optimal level of filling pressure in the left side of the heart in acute myocardial infarction. N Engl J Med 289:1263–1266 —Google Scholar
  95. 16.
    Cyran J, Bolte HD (1981) Parenterale Kombinationstherapie mit Katecholaminen und Vasodilatantien bei koronarer Herzkrankheit. In: Bolte HD (Hrsg) Katecholamine und Vasodilatantien bei Herzinsuffizienz. Springer, Berlin Heidelberg New York, S 55–63 —Google Scholar
  96. 17.
    Cyran J, Hellwig H, Bolte HD, Karabensch FJ, Scherpe A, v. Gosen J, Krüger R, Luderitz B (1978) zum Dosierungsproblem der Nitroglyzerindauerinfusion bei Patienten mit schwerer Herzinsuffizienz. Intensivmed 15:156–160 —Google Scholar
  97. 18.
    Cyran J, Kühnl C, Zähringer J, Bolte HD, Luderitz B (1978) Die Änderung der Hämodynamik des Herzens unter dem kombinierten Einfluß von Nitroglyzerin und Dopamin bei hochgradiger Linksherzinsuffizienz. Z Kardiol 67:759–765 —Google Scholar
  98. 19.
    Dawson JR, Poole-Wilson PA, Sutton GC (1980) Salbutamol in cardiogenic shock complicating acute myocardial infarction. Br Heart J 43:523–526 —Google Scholar
  99. 20.
    Drajer S, Vazquez A, Cercòs H, Torres H, Cohn JL, Romero N, Faerman G, Soifer S, Nijensohn CM (1985) Molsidomine in the treatment of acute heart failure. Am Heart J 109:712–715 —Google Scholar
  100. 21.
    Edwards JD (1985) Right ventricular infarction. In: Vincent JL (ed) Update in intensive care medicine. Springer, Berlin Heidelberg New York, S 236–237-Google Scholar
  101. 22.
    Effert S, Merx W, Meyer J (1982) Akutes Herzversagen, Lungenödem und Schock. Verh Deutsch Ges Inn Med 88:57–65-Google Scholar
  102. 23.
    Erbel R, Meyer J, Lambertz H, Schweizer P, Voelker W, Krebs W, Braun G, Effert S (1982) Hemodynamic effects of prenalterol in patients with ischemic heart disease and congestive cardiomyopathy. Circulation 66:361–369-Google Scholar
  103. 24.
    Fillmore SJ, Guimaràes AC, Scheidt SS, Killip T (1972) Blood-Gas changes and pulmonary hemodynamics following acute myocardial infarction. Circulation 45:583–591-Google Scholar
  104. 25.
    Fowler MB, Timmis AD, Crick JP, Vincent R, Chamberlain DA (1982) Comparison of haemodynamic responses to dobutamine and salbutamol in cardiogenic chock after acute myocardial infarction. Br Med J 284:73–76-Google Scholar
  105. 26.
    Franciosa JA, Dunkman WB, Wilen M, Silverstein SR (1983) “Optimal” left ventricular filling pressure during Nitroprusside infusion for congestive heart failure. Am J Med 74:457–464-Google Scholar
  106. 27.
    Francis GS, Sharma B, Hodges M (1982) Comparative hemodynamic effects of dopamine and dobutamine in patients with acute cardiogenic circulatory collapse. Am Heart J 103:995–1000-Google Scholar
  107. 28.
    Goldstein RA, Passamani ER, Roberts R (1980) A comparison of Digoxin and Dobutamine in patients with acute infarction and cardiac failure. N Engl J Med 303:846–850-Google Scholar
  108. 29.
    Hillen H, Lehmann HU, Hochrein H (1984) Hämodynamische Wirkungen von Prenalterol im Vergleich zum Dopamin und Dobutamin beim kardiogenen Schock. Intensivmed 21:72–76-Google Scholar
  109. 30.
    Hillen H, Witt E, Lehmann HU, Hochrein H (1981) Nitroglycerin, Dopamin und deren kombinierte Anwendung bei schwerer Myokardinsuffizienz. Intensivmed 18:11–16-Google Scholar
  110. 31.
    Hockings BEF, Cope GD, Clarke GM, Taylor RR (1982) Randomized controlled trial of vasodilator therapy after myocardial infarction. Am J Cardiol 48:345–352-Google Scholar
  111. 32.
    Jahrmärker H, Rackwitz R, Haider M (1977) Blutlaktat als Parameter zur Überwachung bei akutem Myokardinfarkt. In: Kaindl F, Pachinger O, Probst P (Hrsg) Die ersten 24 Stunden des Herzinfarktes. Witzstrock, Baden-Baden Köln New York, S 51–53-Google Scholar
  112. 33.
    Jennings K, Gwilt D, Crean P, Turnbull S, Gold R, Julian DG (1982) The clinical cardiovascular pharmacology of Amrinone. A selective cardiotonic agent. Acta Cardiol 1982 (Suppl 28):67–75-Google Scholar
  113. 34.
    Keung ECH, Siskind SJ, Sonnenblick H, Ribner HS, Schwartz WJ, LeJemtel TH (1981) Dobutamine therapy in acute myocardial infarction. JAMA 245:144–146-Google Scholar
  114. 35.
    Klein NA, Siskind SJ, Frishman WH, Sonnenblick EH, LeJemtel TH (1981) Hemodynamic comparison of intravenous Amrinone and Dobutamine in patients with chronic congestive heart failure. Am J Cardiol 48:170–175-Google Scholar
  115. 36.
    Klepzig M, Kleinhans E, Büll U, Strauer BE (1985) Amrinone in Akut-und Langzeittherapie. Z Kardiol 74:85–90-Google Scholar
  116. 37.
    Laggner A, Klein-berger G, Haller J, Lenz K, Sommer G, Druml W (1984) Bedside estimation of extravascular lung water in critically ill patients: comparison of the chest radiograph and the thermal dye technique. Intensive Care Med 10:309–313-Google Scholar
  117. 38.
    Laggner A, Kleinberger G, Graninger W, Lenz K, Druml W, Schneeweiß B (1985) Dynamik und prognostischer Wert des extravaskulären Lungenwassers bei Intensivpatienten. Intensivmed 22:94–97-Google Scholar
  118. 39.
    Lehmann HU, Polensky A, Hochrein H (1984) Isosorbid-5-Mononitrat (IS-5-MN) in der Therapie des akuten Myokardinfarktes. Intensivmed 21:77–83-Google Scholar
  119. 40.
    Leier CV, Heban PT, Huss P, Bush CA, Lewis RP (1978) Comparative systemic and regional hemodynamic effects of Dopamine and Dobutamine in patients with cardiomyopathie heart failure. Circulation 58:466–475-Google Scholar
  120. 41.
    Leier CV, Bambach D, Thompson MJ, Cattaneo SM, Goldberg RJ, Unverferth DV (1981) Central and regional hemodynamic effects of intravenous Isosorbide Dinitrate, Nitroglycerin and Nitroprusside in patients with congestive heart failure. Am J Cardiol 48:1115–1123-Google Scholar
  121. 42.
    LeJemtel TH, Keung E, Sonnenblick EH, Ribner HS, Matsumoto M, Davis R, Schwartz W, Alousi AA, Davolos D (1979) Amrinone: A new non-glycosidic, nonadrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man. Circulation 59:1098–1104-Google Scholar
  122. 43.
    Likoff MJ, Weber KT, Andrews V, Janicki JS (1983) Amrinone: a promising new cardiotonic agent in the treatment of chronic cardiac failure. Herz: 199–205-Google Scholar
  123. 44.
    Loeb HS, Bredakis J, Gunnar RM (1977) Superiority of Dobutamine or Dopamine for Augmentation of cardiac output in patients with chronic low output cardiac failure. Circulation 55:375–381-Google Scholar
  124. 45.
    Loeb HS, Gunnar RM (1981) Treatment of pump failure in acute myocardial infarction. JAMA 245:2093–2096-Google Scholar
  125. 46.
    Loeb HS, Winslow EBJ, Rahimtoola SH, Rosen KM, Gunnar RM (1971) Acute hemodynamic effects of Dopamine in patients with shock. Circulation 44:163–173-Google Scholar
  126. 47.
    Mueller HS (1979) Myokardinfarkt - Kardiogener Schock. Intensivmed 16:115–121-Google Scholar
  127. 48.
    Nikki P, Räsänen J, Tahvanainen J, Mäkeläinen A (1982) Ventilatory pattern in respiratory failure arising from acute myocardial infarction. Crit Care med 10:75–78-Google Scholar
  128. 49.
    Nobis H, Enenkel W (1985) Der derzeitige Stand der intraaortalen Ballongegenpulsation. Intensivmed 22:61–68-Google Scholar
  129. 50.
    Nobis H, Prachar H, Enenkel W (1981) Respiratortherapie bei akutem Myokardinfarkt. Intensivmed 18:192–196-Google Scholar
  130. 51.
    Polensky A, Lehmann HU, Hochrein H (1983) Bedeutung des linksventrikulären Füllungsdruckes für die Herzleistung beim akuten Myokardinfarkt. Intensivmed 20:225–229-Google Scholar
  131. 52.
    Renard M, Jacobs P, Liebens I, Friart A, Bernard R (1985) Effects of Molsidomine on hemodynam-Google Scholar
  132. ics and blood gases in acute myocardial infarction with left heart failure. Am Heart J 109:720–722 —Google Scholar
  133. 53.
    Reifart N, Neidl K, Kaltenbach M, Bussmann WD (1985) Hemodynamic effects of Molsidomine in patients with acute myocardial infarction. Am Heart J 109:708–712 —Google Scholar
  134. 54.
    Richard C, Ricome JL, Rimalho A, Bottineau G, Auzepy P (1983) Combined Hemodynamic effects of Dopamine and Dobutamine in cardiogenic shock. Circulation 67:620–625 —Google Scholar
  135. 55.
    Russel RO, Rachley CE, Pomba J, Hunt D, Polanin C, Volge HT (1970) Effects of increasing left ventricular filling pressure in patients with acute myocardial infarction. J Clin Invest 49:1539–1550 —Google Scholar
  136. 56.
    Schartl M, Dougherty C, Rutsch W, Schmutzler H (1985) Hemodynamic effects of Molsidomine, Isosorbide Dinitrate, and Nifedipine at rest and during exercise. Am Heart J 109:649–653 —Google Scholar
  137. 57.
    Schuster HP (1984) Beatmungstherapie bei Linksherzversagen. Notfallmedizin 7:156–163 —Google Scholar
  138. 58.
    Schuster HP (1984) Die hämodynamischen Auswirkungen der Überdruckbeatmung. Klin Wochenschr 62:56–64 —Google Scholar
  139. 59.
    Siegel LA, Keung E, Siskind SJ, Forman R, Feinberg H, Strom J, Epstathakis D, Sonnenblick EH, LeJemtel TH (1981) Beneficial effects of Amrinone-Hydralazine combination on resting hemodynamics and exercise capacity in patients with severe congestive heart failure. Circulation 63:838–844-Google Scholar
  140. 60.
    Weber KT, Andrews V, Janicki JS, Wilson JR, Fishman AP (1981) Amrinone and exercise performance in patients with chronic heart failure. Am J Cardiol 48:164–169 —Google Scholar
  141. 61.
    Weiß B, Donat K, Ivens K, Schuchart J, Ziegler WJ (1984) Komplikationen und Reanimationserfolge bei akutem Herzinfarkt. Epidemiologische Untersuchung in einer Großstadt. Intensivmed 21:339–344 —Google Scholar
  142. 62.
    Wirtzfeld A, Klein G, Delius W, Himmler C, Vogler E, Davidson J (1978) Dopamin und Dobutamin in der Behandlung der schweren Herzinsuffizienz. Deutsch Med Wochenschr 103:1915–1921 —Google Scholar
  143. 63.
    Wolff G, Grädel E, Hasse J, Gasser D (1974) Günstige Auswirkungen der künstlichen Beatmung auf den großen und kleinen Kreislauf bei Linksherzinsuffizienz. Intensivmed 11:218–223 —Google Scholar
  144. 64.
    Worthley LIG, Tyler P, Moran JL (1985) A comparison of Dopamine, Dobutamine and Isoproterenol in the treatment of shock. Intensive Care Med 11: 13–19Google Scholar

Copyright information

© J. F. Bergmann Verlag, München 1985

Authors and Affiliations

  • K.-D. Grosser
    • 1
  • H. Hochrein
    • 2
  • H. G. Lasch
    • 3
  • A. Sturm
    • 4
  • H. W. Wiechmann
    • 4
  • M. Bitter
    • 4
  • W. Klein
    • 5
  • E. Maurer
    • 5
  • K. Vrécko
    • 5
  • H.-P. Schuster
    • 6
  • H. B. Stähelin
    • 7
  • M. Bergener
    • 8
  • G. Brüschke
    • 9
  • H. J. Fahrländer
    • 10
  • R. Lüthy
    • 11
  • H. Mehnert
    • 12
  • H. H. Raspe
    • 13
  • K. P. Schüren
    • 14
  • H. Losse
    • 15
  • K. Kochsiek
    • 16
  1. 1.KrefeldDeutschland
  2. 2.BerlinDeutschland
  3. 3.Zentrum für Innere MedizinUniversität GießenDeutschland
  4. 4.Medizinische UniversitätsklinikRuhr-Universität Bochum - Marienhospital HerneDeutschland
  5. 5.Medizinische Universitäts-Klinik und Institut für Medizinische ChemiePregl-Laboratorium der Universität GrazDeutschland
  6. 6.Medizinische Klinik IStädtisches Krankenhaus HildesheimDeutschland
  7. 7.Medizinisch-geriatrische KlinikKantonsspital BaselSchweiz
  8. 8.Rheinische LandesklinikKölnDeutschland
  9. 9.Universitätsklinik für Innere MedizinTheodor Brucksch, BerlinDDR
  10. 10.Dept. f. Innere MedizinUniversität BaselSchweiz
  11. 11.Med. Poliklinik UniversitätsspitalZürichSchweiz
  12. 12.3. Med. AbteilungStädtisches Krankenhaus München SchwabingDeutschland
  13. 13.Krankheiten der BewegungsorganeMedizinische Hochschule HannoverDeutschland
  14. 14.1. Innere AbteilungKrankenhaus MoabitBerlinDeutschland
  15. 15.MünsterDeutschland
  16. 16.WürzburgDeutschland

Personalised recommendations